Azenta, Inc. (AZTA)
NASDAQ: AZTA · IEX Real-Time Price · USD
52.18
+0.68 (1.32%)
At close: Apr 26, 2024, 4:00 PM
51.17
-1.01 (-1.94%)
After-hours: Apr 26, 2024, 4:39 PM EDT

Azenta Revenue

Azenta had revenue of $641.02M in the twelve months ending December 31, 2023, with 7.88% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $154.32M, a -13.48% decrease year-over-year. In the fiscal year ending September 30, 2023, Azenta had annual revenue of $665.07M with 19.73% growth.

Revenue (ttm)
$641.02M
Revenue Growth
+7.88%
P/S Ratio
4.54
Revenue / Employee
$183,149
Employees
3,500
Market Cap
2.91B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2023665.07M109.57M19.73%
Sep 30, 2022555.50M41.80M8.14%
Sep 30, 2021513.70M125.17M32.21%
Sep 30, 2020388.54M-392.31M-50.24%
Sep 30, 2019780.85M149.29M23.64%
Sep 30, 2018631.56M104.06M19.73%
Sep 30, 2017527.50M93.49M21.54%
Sep 30, 2016434.01M-118.70M-21.48%
Sep 30, 2015552.71M69.86M14.47%
Sep 30, 2014482.85M60.41M14.30%
Sep 30, 2013422.44M-66.54M-13.61%
Sep 30, 2012488.98M-199.12M-28.94%
Sep 30, 2011688.11M95.13M16.04%
Sep 30, 2010592.97M374.27M171.13%
Sep 30, 2009218.71M-307.66M-58.45%
Sep 30, 2008526.37M-216.89M-29.18%
Sep 30, 2007743.26M135.76M22.35%
Sep 30, 2006607.49M237.72M64.29%
Sep 30, 2005369.78M-165.28M-30.89%
Sep 30, 2004535.05M194.96M57.33%
Sep 30, 2003340.09M35.84M11.78%
Sep 30, 2002304.25M-77.46M-20.29%
Sep 30, 2001381.72M44.53M13.21%
Sep 30, 2000337.18M214.23M174.23%
Sep 30, 1999122.96M5.67M4.83%
Sep 30, 1998117.29M7.86M7.19%
Sep 30, 1997109.43M-3.30M-2.93%
Sep 30, 1996112.73M61.77M121.22%
Sep 30, 199550.96M24.31M91.20%
Sep 30, 199426.65M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Amedisys 2.25B
LivaNova 1.15B
GoodRx Holdings 750.27M
ACADIA Pharmaceuticals 726.44M
Amicus Therapeutics 399.36M
Immunocore Holdings 249.43M
TransMedics Group 241.62M
Olink Holding AB (publ) 169.60M
Revenue Rankings